| Identification | Back Directory | [Name]
C12 NBD L-THREO-SPHINGOSINE | [CAS]
474943-08-3 | [Synonyms]
C12 NBD L-THREO-SPHINGOSINE N-[12-[(7-NITRO-2-1 3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-L-THREO-SPHINGOSINE N-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-L-THREO-SPHINGOSINE;C12-NBD L-THREO-SPHINGOSINE Dodecanamide, N-[(1R,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- | [Molecular Formula]
C36H61N5O6 | [MDL Number]
MFCD03428079 | [MOL File]
474943-08-3.mol | [Molecular Weight]
659.9 |
| Safety Data | Back Directory | [WGK Germany ]
WGK 3 | [Storage Class]
6.1D - Non-combustible acute toxic Cat.3 toxic hazardous materials or hazardous materials causing chronic effects | [Hazard Classifications]
Acute Tox. 3 Inhalation Acute Tox. 4 Oral Carc. 2 Eye Irrit. 2 Repr. 2 Skin Irrit. 2 STOT RE 1 STOT SE 3 |
| Hazard Information | Back Directory | [Uses]
C12-NBD-L-Threo-sphingosine is an ester product. | [Biological Activity]
Sphingosine is uniquely produced by de-acylation of ceramide. It can be converted back to ceramide by the scavenger pathway. Several studies suggest th at sphingosine functions as a tumor-suppressor lipid th at mediates growth arrestsenescenceapoptosis and differentiation. Treatment of cells with sphingosine is known to inhibit the activity of the mitogen activated protein kinases (MAPKs)extracellular signal-regulated kinases (Erk-1 and Erk-2)and activate stress-activated protein kinases (SAPKs) such as Jun amino-terminal kinases (JNK) and p38. |
|
|